Andrew Technologies LLC<\/strong> Becton, Dickinson and Company<\/strong> BioScale, Inc.<\/strong> CarboFix, Ltd. Celluman (now part of Evotec AG)<\/strong> ExSAR Corporation<\/strong> Gadeta, BV<\/strong> Genentech, Inc.<\/strong> ImaCor Inc.<\/strong> LinguaFlex, Inc.<\/strong> Lumicell, Inc. <\/strong> Oncogene Science, Inc. <\/strong> NovoCure Ltd.<\/strong> Nuclea Biotechnologies Inc.<\/strong> NuGene Technologies, Inc.<\/strong> Pharmos Corporation <\/strong> SIBIA Neurosciences, Inc.<\/strong> Theragen, Inc.<\/strong> VisionScope Technologies<\/strong> WFD Ventures portfolio companies<\/strong> Wyeth, Pharmaceuticals, Inc. <\/strong> Selected Executive Search Experience Andrew Technologies LLCA Medical Device company focused on Aesthetic Surgery\u2013 President and CEO\u2013 Vice President, Product Development Becton, Dickinson and CompanyA global medical technology company\u2013 Director of Business Development, Transdermals\u2013 Vice President, Technology Development, BD Labware BioScale, Inc.A protein measurement technology company\u2013 Member of the …<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.catalyx.com\/wp-json\/wp\/v2\/pages\/116"}],"collection":[{"href":"https:\/\/www.catalyx.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.catalyx.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.catalyx.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.catalyx.com\/wp-json\/wp\/v2\/comments?post=116"}],"version-history":[{"count":3,"href":"https:\/\/www.catalyx.com\/wp-json\/wp\/v2\/pages\/116\/revisions"}],"predecessor-version":[{"id":334,"href":"https:\/\/www.catalyx.com\/wp-json\/wp\/v2\/pages\/116\/revisions\/334"}],"wp:attachment":[{"href":"https:\/\/www.catalyx.com\/wp-json\/wp\/v2\/media?parent=116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
A Medical Device company focused on Aesthetic Surgery<\/em>
\u2013 President and CEO
\u2013 Vice President, Product Development<\/p>\n
A global medical technology company<\/em>
\u2013 Director of Business Development, Transdermals
\u2013 Vice President, Technology Development, BD Labware<\/p>\n
A protein measurement technology company<\/em>
\u2013 Member of the Board of Directors<\/p>\n
<\/strong>Manufacturer of Innovtive Orthopedic Spine and Trauma Implants
<\/em>\u2013 President, U.S.
\u2013 Vice President, Sales & Marketing \u2013 U.S. Spine
\u2013 Vice President, Sales & Marketing \u2013 U.S. Trauma
\u2013 Regional VP\u2019s and Directors of Sales (4)<\/p>\n
Cellular-based systems biology company<\/em>
\u2013 Director of Manufacturing<\/p>\n
A development-stage company dedicated to identifying, developing and commercializing small molecule therapeutics for protein misfolding diseases<\/em>
\u2013 President and CEO<\/p>\n
A Netherlands-based Immuno-Oncology Company<\/em>
\u2013 Chief Medical Officer<\/p>\n
A biotechnology company acquired by Hoffmann-La Roche, Inc.<\/em>
\u2013 Sr. Director, Capital Projects
\u2013 Numerous Engineering and Process Development positions<\/p>\n
An Implantable Cardiology Medical Device Imaging Company<\/em>
\u2013 President and CEO<\/p>\n
An Implantable Minimally-Invasive Sleep Apnea Company<\/em>
\u2013 President and CEO
\u2013 Vice President, Clinical and Regulatory Affairs
\u2013 Member, Board of Directors<\/p>\n
A potentially disruptive, VC-backed Device and Diagnostics Company that detects even a single cancer cell left behind at the time of surgery.<\/em>
\u2013 Member, Board of Directors<\/p>\n
A biotechnology company focused on cancer, diabetes and obesity<\/em>
(Now OSI Pharmaceuticals, Inc., a wholly-owned subsidiary of Astellas US Holding, Inc., a holding company owned by Astellas Pharma Inc.)<\/em>
\u2013 President and CEO
\u2013 Vice President, Marketing & Business Development<\/p>\n
A public Medical Device company (NASDAQ: NVCR) focused on oncology therapeutics for solid tumors. The company\u2019s first two products \u2013 for recurrent and newly diagnosed Glioblastoma \u2013 have been approved by the FDA and are broadly marketed.<\/em>
\u2013 Vice Chairman of the Board and Chair of the Global Commercialization Team
\u2013 Chief Financial Officer
\u2013 Independent Member of the Board of Directors<\/p>\n
A Companion diagnostics Company focused on Cancer and Diabetes<\/em>
\u2013 President and CEO
\u2013 Vice President, Sales and Marketing<\/p>\n
A development-stage anti-cancer company<\/em>
\u2013 Member, Board of Directors<\/p>\n
A biopharmaceutical company focused on inflammation, pain and diseases of the immune system<\/em>
\u2013 President and COO
\u2013 Sr. Vice President and CFO
\u2013 Sr. Vice President, Clinical Research
\u2013 Sr. Director of Investor Relations, Public Relations and Corporate Communications<\/p>\n
A neuroscience company focused on ion-channel receptors acquired by Merck & Co.<\/em>
\u2013 President and CEO<\/p>\n
A Gene Therapy Company acquired by GenVec, Inc.<\/em>
\u2013 President and CEO<\/p>\n
A diagnostics company focused on endoscopy and sports medicine.<\/em>
\u2013 President and CEO<\/p>\n
A Venture Capital Company focused on medical devices and healthcare IT<\/em>
\u2013 Chief Executive Officers (4)
\u2013 Chief Financial Officer
\u2013 Independent Member, Board of Directors (2)
\u2013 Vice Chairman of the Board and Chair, Global Commercialization
\u2013 Vice President, Product Development
\u2013 Vice President, Clinical and Regulatory Affairs<\/p>\n
A global biopharmaceutical company acquired by Pfizer, Inc. and spun out as Zoetis Inc.<\/em>
\u2013 Asst. Vice President, Pharmaceutical R & D, Fort Dodge Animal Health Div.<\/p>","protected":false},"excerpt":{"rendered":"